{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T04:20:09Z","timestamp":1794630009117,"version":"4.9.1"},"reference-count":178,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:00:00Z","timestamp":1760659200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:00:00Z","timestamp":1760659200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Psychiatry"],"DOI":"10.1038\/s41398-025-03619-6","type":"journal-article","created":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T15:44:48Z","timestamp":1760715888000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Alcohol addiction and Alzheimer\u2019s disease: a molecular collision course"],"prefix":"10.1038","volume":"15","author":[{"given":"Jia-Sheng","family":"Chang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"He-Zhou","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke-Bin","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9964-9229","authenticated-orcid":false,"given":"Ling-Qiang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,17]]},"reference":[{"key":"3619_CR1","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/S2215-0366(16)00104-8","volume":"3","author":"GF Koob","year":"2016","unstructured":"Koob GF, Volkow ND. Neurobiology of addiction: a neurocircuitry analysis. Lancet Psychiatry. 2016;3:760\u201373. https:\/\/doi.org\/10.1016\/S2215-0366(16)00104-8.","journal-title":"Lancet Psychiatry"},{"key":"3619_CR2","doi-asserted-by":"publisher","unstructured":"American Psychiatric Association. Diagnostic and statistical manual of mental disorders. Fifth Edition (DSM-5). American Psychiatric Association; 2013. https:\/\/doi.org\/10.1176\/appi.books.9780890425596","DOI":"10.1176\/appi.books.9780890425596"},{"key":"3619_CR3","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s41386-019-0446-0","volume":"45","author":"GF Koob","year":"2020","unstructured":"Koob GF, Colrain IM. Alcohol use disorder and sleep disturbances: a feed-forward allostatic framework. Neuropsychopharmacol. 2020;45:141\u201365. https:\/\/doi.org\/10.1038\/s41386-019-0446-0.","journal-title":"Neuropsychopharmacol"},{"key":"3619_CR4","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.2147\/NDT.S136122","volume":"13","author":"D Sampath","year":"2017","unstructured":"Sampath D, Sathyanesan M, Newton SS. Cognitive dysfunction in major depression and Alzheimer\u2019s disease is associated with hippocampal-prefrontal cortex dysconnectivity. Neuropsychiatr Dis Treat. 2017;13:1509\u201319. https:\/\/doi.org\/10.2147\/NDT.S136122.","journal-title":"Neuropsychiatr Dis Treat"},{"key":"3619_CR5","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1111\/add.13757","volume":"112","author":"J Rehm","year":"2017","unstructured":"Rehm J, Gmel GE, Gmel G, Hasan OSM, Imtiaz S, Popova S, et al. The relationship between different dimensions of alcohol use and the burden of disease-an update. Addict Abingdon Engl. 2017;112:968\u20131001. https:\/\/doi.org\/10.1111\/add.13757.","journal-title":"Addict Abingdon Engl"},{"key":"3619_CR6","doi-asserted-by":"publisher","first-page":"e124","DOI":"10.1016\/S2468-2667(18)30022-7","volume":"3","author":"M Schwarzinger","year":"2018","unstructured":"Schwarzinger M, Pollock BG, Hasan OSM, Dufouil C, Rehm J, QalyDays Study Group. Contribution of alcohol use disorders to the burden of dementia in France 2008-13: a nationwide retrospective cohort study. Lancet Public Health. 2018;3:e124\u2013e132. https:\/\/doi.org\/10.1016\/S2468-2667(18)30022-7.","journal-title":"Lancet Public Health"},{"key":"3619_CR7","doi-asserted-by":"publisher","first-page":"k2927","DOI":"10.1136\/bmj.k2927","volume":"362","author":"S Sabia","year":"2018","unstructured":"Sabia S, Fayosse A, Dumurgier J, Dugravot A, Akbaraly T, Britton A, et al. Alcohol consumption and risk of dementia: 23 year follow-up of Whitehall II cohort study. BMJ. 2018;362:k2927 https:\/\/doi.org\/10.1136\/bmj.k2927.","journal-title":"BMJ"},{"key":"3619_CR8","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.arr.2015.07.001","volume":"23","author":"M El Haj","year":"2015","unstructured":"El Haj M, Antoine P, Nandrino JL, Kapogiannis D. Autobiographical memory decline in Alzheimer\u2019s disease, a theoretical and clinical overview. Ageing Res Rev. 2015;23:183\u201392. https:\/\/doi.org\/10.1016\/j.arr.2015.07.001.","journal-title":"Ageing Res Rev"},{"key":"3619_CR9","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/S0140-6736(15)01124-1","volume":"388","author":"P Scheltens","year":"2016","unstructured":"Scheltens P, Blennow K, Breteler MMB, de Strooper B, Frisoni GB, Salloway S, et al. Alzheimer\u2019s disease. Lancet Lond Engl. 2016;388:505\u201317. https:\/\/doi.org\/10.1016\/S0140-6736(15)01124-1.","journal-title":"Lancet Lond Engl"},{"key":"3619_CR10","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/S0140-6736(09)60009-X","volume":"373","author":"MA Schuckit","year":"2009","unstructured":"Schuckit MA. Alcohol-use disorders. Lancet Lond Engl. 2009;373:492\u2013501. https:\/\/doi.org\/10.1016\/S0140-6736(09)60009-X.","journal-title":"Lancet Lond Engl"},{"key":"3619_CR11","doi-asserted-by":"publisher","first-page":"910298","DOI":"10.3389\/fnmol.2022.910298","volume":"15","author":"A Ramos","year":"2022","unstructured":"Ramos A, Joshi RS, Szabo G. Innate immune activation: parallels in alcohol use disorder and Alzheimer\u2019s disease. Front Mol Neurosci. 2022;15:910298 https:\/\/doi.org\/10.3389\/fnmol.2022.910298.","journal-title":"Front Mol Neurosci"},{"key":"3619_CR12","doi-asserted-by":"publisher","first-page":"105967","DOI":"10.1016\/j.nbd.2022.105967","volume":"177","author":"SM Day","year":"2023","unstructured":"Day SM, Gironda SC, Clarke CW, Snipes JA, Nicol NI, Kamran H, et al. Ethanol exposure alters Alzheimer\u2019s-related pathology, behavior, and metabolism in APP\/PS1 mice. Neurobiol Dis. 2023;177:105967 https:\/\/doi.org\/10.1016\/j.nbd.2022.105967.","journal-title":"Neurobiol Dis"},{"key":"3619_CR13","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.3390\/cells13141173","volume":"13","author":"M Kumar","year":"2024","unstructured":"Kumar M, Swanson N, Ray S, Buch S, Saraswathi V, Sil S. Astrocytes in Amyloid Generation and Alcohol Metabolism: Implications of Alcohol Use in Neurological Disorder(s). Cells. 2024;13:1173 https:\/\/doi.org\/10.3390\/cells13141173.","journal-title":"Cells"},{"key":"3619_CR14","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1186\/s12871-023-02178-x","volume":"23","author":"X Wu","year":"2023","unstructured":"Wu X, Zhang N, Zhou B, Liu S, Wang F, Wang J, et al. Alcohol consumption may be associated with postoperative delirium in the elderly: the PNDABLE study. BMC Anesthesiol. 2023;23:222 https:\/\/doi.org\/10.1186\/s12871-023-02178-x.","journal-title":"BMC Anesthesiol"},{"key":"3619_CR15","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1007\/s12035-010-8138-0","volume":"41","author":"MA Collins","year":"2010","unstructured":"Collins MA, Neafsey EJ, Wang K, Achille NJ, Mitchell RM, Sivaswamy S. Moderate ethanol preconditioning of rat brain cultures engenders neuroprotection against dementia-inducing neuroinflammatory proteins: possible signaling mechanisms. Mol Neurobiol. 2010;41:420\u20135. https:\/\/doi.org\/10.1007\/s12035-010-8138-0.","journal-title":"Mol Neurobiol"},{"key":"3619_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-75202-w","volume":"14","author":"S Kang","year":"2024","unstructured":"Kang S, Lee J, Ali DN, Choi S, Nesbitt J, Min PH, et al. Low to moderate ethanol exposure reduces astrocyte-induced neuroinflammatory signaling and cognitive decline in presymptomatic APP\/PS1 mice. Sci Rep. 2024;14:23989. https:\/\/doi.org\/10.1038\/s41598-024-75202-w.","journal-title":"Sci Rep."},{"key":"3619_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-018-1184-7","volume":"15","author":"S Kalinin","year":"2018","unstructured":"Kalinin S, Gonz\u00e1lez-Prieto M, Scheiblich H, Lisi L, Kusumo H, Heneka MT, et al. Transcriptome analysis of alcohol-treated microglia reveals downregulation of beta amyloid phagocytosis. J Neuroinflammation. 2018;15:141. https:\/\/doi.org\/10.1186\/s12974-018-1184-7.","journal-title":"J Neuroinflammation"},{"key":"3619_CR18","doi-asserted-by":"publisher","first-page":"3272","DOI":"10.3390\/ijms26073272","volume":"26","author":"H Song","year":"2025","unstructured":"Song H, Lee J, Lee Y, Kim S, Kang S. Reactive oxygen species as a common pathological link between alcohol use disorder and Alzheimer\u2019s disease with therapeutic implications. Int J Mol Sci. 2025;26:3272 https:\/\/doi.org\/10.3390\/ijms26073272.","journal-title":"Int J Mol Sci"},{"key":"3619_CR19","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.bbi.2019.06.029","volume":"85","author":"Q Liu","year":"2020","unstructured":"Liu Q, Yan L, Huang M, Zeng H, Satyanarayanan SK, Shi Z, et al. Experimental alcoholism primes structural and functional impairment of the glymphatic pathway. Brain Behav Immun. 2020;85:106\u201319. https:\/\/doi.org\/10.1016\/j.bbi.2019.06.029.","journal-title":"Brain Behav Immun"},{"key":"3619_CR20","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.alcohol.2022.08.013","volume":"107","author":"P Marsland","year":"2023","unstructured":"Marsland P, Vore AS, DaPrano E, Paluch JM, Blackwell AA, Varlinskaya EI, et al. Sex-specific effects of ethanol consumption in older Fischer 344 rats on microglial dynamics and A\u03b2((1-42)) accumulation. Alcohol Fayettev N. 2023;107:108\u201318. https:\/\/doi.org\/10.1016\/j.alcohol.2022.08.013.","journal-title":"Alcohol Fayettev N."},{"key":"3619_CR21","doi-asserted-by":"publisher","first-page":"e25337","DOI":"10.1002\/jnr.25337","volume":"102","author":"F Tamnanloo","year":"2024","unstructured":"Tamnanloo F, Chen X, Oliveira MM, Tremblay M, Rose CF. Excessive intragastric alcohol administration exacerbates hepatic encephalopathy and provokes neuronal cell death in male rats with chronic liver disease. J Neurosci Res. 2024;102:e25337 https:\/\/doi.org\/10.1002\/jnr.25337.","journal-title":"J Neurosci Res"},{"key":"3619_CR22","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.tox.2019.03.001","volume":"418","author":"KW Nkpaa","year":"2019","unstructured":"Nkpaa KW, Amadi BA, Wegwu MO, Farombi EO. Ethanol increases manganese-Induced spatial learning and memory deficits via oxidative\/nitrosative stress induced p53 dependent\/independent hippocampal apoptosis. Toxicology. 2019;418:51\u201361. https:\/\/doi.org\/10.1016\/j.tox.2019.03.001.","journal-title":"Toxicology"},{"key":"3619_CR23","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.neuroscience.2019.03.018","volume":"406","author":"C Tapia-Rojas","year":"2019","unstructured":"Tapia-Rojas C, Torres AK, Quintanilla RA. Adolescence binge alcohol consumption induces hippocampal mitochondrial impairment that persists during the adulthood. Neuroscience. 2019;406:356\u201368. https:\/\/doi.org\/10.1016\/j.neuroscience.2019.03.018.","journal-title":"Neuroscience"},{"key":"3619_CR24","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/j.bbrc.2020.05.160","volume":"528","author":"RG Mira","year":"2020","unstructured":"Mira RG, Lira M, Quintanilla RA, Cerpa W. Alcohol consumption during adolescence alters the hippocampal response to traumatic brain injury. Biochem Biophys Res Commun. 2020;528:514\u20139. https:\/\/doi.org\/10.1016\/j.bbrc.2020.05.160.","journal-title":"Biochem Biophys Res Commun"},{"key":"3619_CR25","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.biopha.2017.04.077","volume":"91","author":"P Rajput","year":"2017","unstructured":"Rajput P, Jangra A, Kwatra M, Mishra A, Lahkar M. Alcohol aggravates stress-induced cognitive deficits and hippocampal neurotoxicity: Protective effect of melatonin. Biomed Pharmacother. 2017;91:457\u201366. https:\/\/doi.org\/10.1016\/j.biopha.2017.04.077.","journal-title":"Biomed Pharmacother"},{"key":"3619_CR26","doi-asserted-by":"publisher","first-page":"927","DOI":"10.3390\/cells13110927","volume":"13","author":"B Ray","year":"2024","unstructured":"Ray B, Rungratanawanich W, LeFort KR, Chidambaram SB, Song BJ. Mitochondrial aldehyde dehydrogenase 2 (ALDH2) protects against binge alcohol-mediated gut and brain injury. Cells. 2024;13:927 https:\/\/doi.org\/10.3390\/cells13110927.","journal-title":"Cells"},{"key":"3619_CR27","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1097\/01.alc.0000171932.13148.cf","volume":"29","author":"JJ Grisel","year":"2005","unstructured":"Grisel JJ, Chen WJA. Antioxidant pretreatment does not ameliorate alcohol-induced Purkinje cell loss in the developing rat cerebellum. Alcohol Clin Exp Res. 2005;29:1223\u20139. https:\/\/doi.org\/10.1097\/01.alc.0000171932.13148.cf.","journal-title":"Alcohol Clin Exp Res"},{"key":"3619_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-021-02243-7","volume":"18","author":"V Macht","year":"2021","unstructured":"Macht V, Vetreno R, Elchert N, Crews F. Galantamine prevents and reverses neuroimmune induction and loss of adult hippocampal neurogenesis following adolescent alcohol exposure. J Neuroinflammation. 2021;18:212. https:\/\/doi.org\/10.1186\/s12974-021-02243-7.","journal-title":"J Neuroinflammation"},{"key":"3619_CR29","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.toxlet.2022.02.006","volume":"360","author":"Y Takahashi","year":"2022","unstructured":"Takahashi Y, Okano H, Takashima K, Ojiro R, Tang Q, Ozawa S, et al. Oral exposure to high-dose ethanol for 28 days in rats reduces neural stem cells and immediate nascent neural progenitor cells as well as FOS-expressing newborn granule cells in adult hippocampal neurogenesis. Toxicol Lett. 2022;360:20\u201332. https:\/\/doi.org\/10.1016\/j.toxlet.2022.02.006.","journal-title":"Toxicol Lett"},{"key":"3619_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.tox.2021.152958","volume":"462","author":"Y Takahashi","year":"2021","unstructured":"Takahashi Y, Yamashita R, Okano H, Takashima K, Ogawa B, Ojiro R, et al. Aberrant neurogenesis and late onset suppression of synaptic plasticity as well as sustained neuroinflammation in the hippocampal dentate gyrus after developmental exposure to ethanol in rats. Toxicology. 2021;462:152958. https:\/\/doi.org\/10.1016\/j.tox.2021.152958.","journal-title":"Toxicology"},{"key":"3619_CR31","doi-asserted-by":"publisher","first-page":"368504211018943","DOI":"10.1177\/00368504211018943","volume":"104","author":"CM Goeke","year":"2021","unstructured":"Goeke CM, Hashimoto JG, Guizzetti M, Vitalone A. Effects of ethanol-and choline-treated astrocytes on hippocampal neuron neurite outgrowth in vitro. Sci Prog. 2021;104:368504211018943 https:\/\/doi.org\/10.1177\/00368504211018943.","journal-title":"Sci Prog"},{"key":"3619_CR32","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1111\/acer.13608","volume":"42","author":"D Khatri","year":"2018","unstructured":"Khatri D, Laroche G, Grant ML, Jones VM, Vetreno RP, Crews FT, et al. Acute ethanol inhibition of adult hippocampal neurogenesis involves CB1 cannabinoid receptor signaling. Alcohol Clin Exp Res. 2018;42:718\u201326. https:\/\/doi.org\/10.1111\/acer.13608.","journal-title":"Alcohol Clin Exp Res"},{"key":"3619_CR33","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.neuro.2022.11.008","volume":"94","author":"M Gal\u00e1n-Llario","year":"2023","unstructured":"Gal\u00e1n-Llario M, Rodr\u00edguez-Zapata M, Gramage E, Vicente-Rodr\u00edguez M, Font\u00e1n-Baselga T, Ovejero-Benito MC, et al. Receptor protein tyrosine phosphatase \u03b2\/\u03b6 regulates loss of neurogenesis in the mouse hippocampus following adolescent acute ethanol exposure. Neurotoxicology. 2023;94:98\u2013107. https:\/\/doi.org\/10.1016\/j.neuro.2022.11.008.","journal-title":"Neurotoxicology"},{"key":"3619_CR34","doi-asserted-by":"publisher","first-page":"114881","DOI":"10.1016\/j.taap.2020.114881","volume":"390","author":"K Lv","year":"2020","unstructured":"Lv K, Yang C, Xiao R, Yang L, Liu T, Zhang R, et al. Dexmedetomidine attenuates ethanol-induced inhibition of hippocampal neurogenesis in neonatal mice. Toxicol Appl Pharm. 2020;390:114881 https:\/\/doi.org\/10.1016\/j.taap.2020.114881.","journal-title":"Toxicol Appl Pharm"},{"key":"3619_CR35","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1007\/s12640-017-9816-8","volume":"33","author":"JF Agostini","year":"2018","unstructured":"Agostini JF, To\u00e9 HCZD, Vieira KM, Baldin SL, Costa NLF, Cruz CU, et al. Cholinergic system and oxidative stress changes in the brain of a zebrafish model chronically exposed to ethanol. Neurotox Res. 2018;33:749\u201358. https:\/\/doi.org\/10.1007\/s12640-017-9816-8.","journal-title":"Neurotox Res"},{"key":"3619_CR36","doi-asserted-by":"publisher","first-page":"2629","DOI":"10.3390\/ijms25052629","volume":"25","author":"HL Lee","year":"2024","unstructured":"Lee HL, Kim JM, Go MJ, Lee HS, Kim JH, Heo HJ. Fermented Protaetia brevitarsis larvae improves neurotoxicity in chronic ethanol-induced-dementia mice via suppressing AKT and NF-\u03baB signaling pathway. Int J Mol Sci. 2024;25:2629 https:\/\/doi.org\/10.3390\/ijms25052629.","journal-title":"Int J Mol Sci"},{"key":"3619_CR37","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.brainres.2017.06.023","volume":"1670","author":"G Pepeu","year":"2017","unstructured":"Pepeu G, Grazia Giovannini M. The fate of the brain cholinergic neurons in neurodegenerative diseases. Brain Res. 2017;1670:173\u201384. https:\/\/doi.org\/10.1016\/j.brainres.2017.06.023.","journal-title":"Brain Res"},{"key":"3619_CR38","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.neurobiolaging.2016.11.016","volume":"51","author":"W Doehner","year":"2017","unstructured":"Doehner W, Pra\u00dfe L, Wolpers J, Br\u00fcckner MK, Ueberham U, Arendt T. Transgenerational transmission of an anticholinergic endophenotype with memory dysfunction. Neurobiol Aging. 2017;51:19\u201330. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2016.11.016.","journal-title":"Neurobiol Aging"},{"key":"3619_CR39","doi-asserted-by":"publisher","first-page":"10011","DOI":"10.1039\/d0fo02042g","volume":"11","author":"C Lu","year":"2020","unstructured":"Lu C, Gao R, Lv J, Chen Y, Li S, Zhang L, et al. Neuroprotective effects of soy isoflavones on chronic ethanol-induced dementia in male ICR mice. Food Funct. 2020;11:10011\u201321. https:\/\/doi.org\/10.1039\/d0fo02042g.","journal-title":"Food Funct"},{"key":"3619_CR40","doi-asserted-by":"publisher","first-page":"91","DOI":"10.54548\/njps.v38i1.13","volume":"38","author":"IO Ishola","year":"2023","unstructured":"Ishola IO, Olubodun-Obadun TG, Akinwande AS, Adeyemi OO. Cajanus cajan (L) Millsp. seed extract ameliorates scopolamine-induced amnesia through increase in antioxidant defense mechanisms and cholinergic neurotransmission. Niger J Physiol Sci. 2023;38:91\u201399. https:\/\/doi.org\/10.54548\/njps.v38i1.13.","journal-title":"Niger J Physiol Sci"},{"key":"3619_CR41","doi-asserted-by":"publisher","first-page":"199","DOI":"10.4162\/nrp.2018.12.3.199","volume":"12","author":"SNS Reid","year":"2018","unstructured":"Reid SNS, Ryu JK, Kim Y, Jeon BH. GABA-enriched fermented Laminaria japonica improves cognitive impairment and neuroplasticity in scopolamine- and ethanol-induced dementia model mice. Nutr Res Pr. 2018;12:199\u2013207. https:\/\/doi.org\/10.4162\/nrp.2018.12.3.199.","journal-title":"Nutr Res Pr"},{"key":"3619_CR42","doi-asserted-by":"publisher","first-page":"a012195","DOI":"10.1101\/cshperspect.a012195","volume":"2","author":"M Roberto","year":"2012","unstructured":"Roberto M, Gilpin NW, Siggins GR. The central amygdala and alcohol: role of \u03b3-aminobutyric acid, glutamate, and neuropeptides. Cold Spring Harb Perspect Med. 2012;2:a012195 https:\/\/doi.org\/10.1101\/cshperspect.a012195.","journal-title":"Cold Spring Harb Perspect Med"},{"key":"3619_CR43","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1038\/s41386-018-0290-7","volume":"44","author":"VA Jimenez","year":"2019","unstructured":"Jimenez VA, Herman MA, Cuzon Carlson VC, Walter NA, Grant KA, Roberto M. Synaptic adaptations in the central amygdala and hypothalamic paraventricular nucleus associated with protracted ethanol abstinence in male rhesus monkeys. Neuropsychopharmacol. 2019;44:982\u201393. https:\/\/doi.org\/10.1038\/s41386-018-0290-7.","journal-title":"Neuropsychopharmacol"},{"key":"3619_CR44","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.biopsych.2009.11.007","volume":"67","author":"M Roberto","year":"2010","unstructured":"Roberto M, Cruz MT, Gilpin NW, Sabino V, Schweitzer P, Bajo M, et al. Corticotropin releasing factor-induced amygdala gamma-aminobutyric Acid release plays a key role in alcohol dependence. Biol Psychiatry. 2010;67:831\u20139. https:\/\/doi.org\/10.1016\/j.biopsych.2009.11.007.","journal-title":"Biol Psychiatry"},{"key":"3619_CR45","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1111\/bph.17335","volume":"182","author":"EH Mitten","year":"2025","unstructured":"Mitten EH, Souders A, Marron Fernandez de Velasco E, Aguado C, Luj\u00e1n R, Wickman K. Chronic ethanol exposure in mice evokes pre- and postsynaptic deficits in GABAergic transmission in ventral tegmental area GABA neurons. Br J Pharm. 2025;182:69\u201386. https:\/\/doi.org\/10.1111\/bph.17335.","journal-title":"Br J Pharm"},{"key":"3619_CR46","doi-asserted-by":"publisher","first-page":"E3745","DOI":"10.1073\/pnas.1406768111","volume":"111","author":"S Spiga","year":"2014","unstructured":"Spiga S, Talani G, Mulas G, Licheri V, Fois GR, Muggironi G, et al. Hampered long-term depression and thin spine loss in the nucleus accumbens of ethanol-dependent rats. Proc Natl Acad Sci USA. 2014;111:E3745\u20133754. https:\/\/doi.org\/10.1073\/pnas.1406768111.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3619_CR47","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/npp.2008.99","volume":"34","author":"C Xiao","year":"2009","unstructured":"Xiao C, Shao XM, Olive MF, Griffin WC 3rd, Li KY, Krnjevi\u0107 K, et al. Ethanol facilitates glutamatergic transmission to dopamine neurons in the ventral tegmental area. Neuropsychopharmacol. 2009;34:307\u201318. https:\/\/doi.org\/10.1038\/npp.2008.99.","journal-title":"Neuropsychopharmacol"},{"key":"3619_CR48","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/j.biopsych.2011.02.004","volume":"69","author":"NW Gilpin","year":"2011","unstructured":"Gilpin NW, Misra K, Herman MA, Cruz MT, Koob GF, Roberto M. Neuropeptide Y opposes alcohol effects on gamma-aminobutyric acid release in amygdala and blocks the transition to alcohol dependence. Biol Psychiatry. 2011;69:1091\u20139. https:\/\/doi.org\/10.1016\/j.biopsych.2011.02.004.","journal-title":"Biol Psychiatry"},{"key":"3619_CR49","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.bbi.2018.10.009","volume":"75","author":"RR Patel","year":"2019","unstructured":"Patel RR, Khom S, Steinman MQ, Varodayan FP, Kiosses WB, Hedges DM, et al. IL-1\u03b2 expression is increased and regulates GABA transmission following chronic ethanol in mouse central amygdala. Brain Behav Immun. 2019;75:208\u201319. https:\/\/doi.org\/10.1016\/j.bbi.2018.10.009.","journal-title":"Brain Behav Immun"},{"key":"3619_CR50","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1038\/npp.2015.353","volume":"41","author":"MH Patton","year":"2016","unstructured":"Patton MH, Roberts BM, Lovinger DM, Mathur BN. Ethanol disinhibits dorsolateral striatal medium spiny neurons through activation of a presynaptic delta opioid receptor. Neuropsychopharmacol. 2016;41:1831\u201340. https:\/\/doi.org\/10.1038\/npp.2015.353.","journal-title":"Neuropsychopharmacol"},{"key":"3619_CR51","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1038\/npp.2013.308","volume":"39","author":"M Kallupi","year":"2014","unstructured":"Kallupi M, Varodayan FP, Oleata CS, Correia D, Luu G, Roberto M. Nociceptin\/orphanin FQ decreases glutamate transmission and blocks ethanol-induced effects in the central amygdala of naive and ethanol-dependent rats. Neuropsychopharmacol. 2014;39:1081\u201392. https:\/\/doi.org\/10.1038\/npp.2013.308.","journal-title":"Neuropsychopharmacol"},{"key":"3619_CR52","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.drugalcdep.2015.01.019","volume":"150","author":"AN Karkhanis","year":"2015","unstructured":"Karkhanis AN, Rose JH, Huggins KN, Konstantopoulos JK, Jones SR. Chronic intermittent ethanol exposure reduces presynaptic dopamine neurotransmission in the mouse nucleus accumbens. Drug Alcohol Depend. 2015;150:24\u201330. https:\/\/doi.org\/10.1016\/j.drugalcdep.2015.01.019.","journal-title":"Drug Alcohol Depend"},{"key":"3619_CR53","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1038\/npp.2016.190","volume":"42","author":"H Trantham-Davidson","year":"2017","unstructured":"Trantham-Davidson H, Centanni SW, Garr SC, New NN, Mulholland PJ, Gass JT, et al. Binge-like alcohol exposure during adolescence disrupts dopaminergic neurotransmission in the adult prelimbic cortex. Neuropsychopharmacol. 2017;42:1024\u201336. https:\/\/doi.org\/10.1038\/npp.2016.190.","journal-title":"Neuropsychopharmacol"},{"key":"3619_CR54","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1159\/000521103","volume":"81","author":"G Spitta","year":"2022","unstructured":"Spitta G, Gleich T, Zacharias K, Butler O, Buchert R, Gallinat J. Extrastriatal dopamine D2\/3 receptor availability in alcohol use disorder and individuals at high risk. Neuropsychobiology. 2022;81:215\u201324. https:\/\/doi.org\/10.1159\/000521103.","journal-title":"Neuropsychobiology"},{"key":"3619_CR55","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1111\/acer.13076","volume":"40","author":"CA Marcinkiewcz","year":"2016","unstructured":"Marcinkiewcz CA, Lowery-Gionta EG, Kash TL. Serotonin\u2019s complex role in alcoholism: implications for treatment and future research. Alcohol Clin Exp Res. 2016;40:1192\u2013201. https:\/\/doi.org\/10.1111\/acer.13076.","journal-title":"Alcohol Clin Exp Res"},{"key":"3619_CR56","doi-asserted-by":"publisher","first-page":"874","DOI":"10.3390\/cells11050874","volume":"11","author":"M Zaniewska","year":"2022","unstructured":"Zaniewska M, Mosienko V, Bader M, Alenina N. Tph2 gene expression defines ethanol drinking behavior in mice. Cells. 2022;11:874 https:\/\/doi.org\/10.3390\/cells11050874.","journal-title":"Cells"},{"key":"3619_CR57","doi-asserted-by":"publisher","first-page":"114057","DOI":"10.1016\/j.expneurol.2022.114057","volume":"353","author":"SL Ruyak","year":"2022","unstructured":"Ruyak SL, Noor S, DiDomenico J, Sun MS, Fernandez Oropeza AK, Rodriguez DE, et al. Effects of prenatal opioid and alcohol exposures on immune and serotonin factors in human placenta. Exp Neurol. 2022;353:114057 https:\/\/doi.org\/10.1016\/j.expneurol.2022.114057.","journal-title":"Exp Neurol"},{"key":"3619_CR58","doi-asserted-by":"publisher","first-page":"106822","DOI":"10.1016\/j.ntt.2019.106822","volume":"75","author":"MCM Alexandre","year":"2019","unstructured":"Alexandre MCM, Mendes NV, Torres CA, Baldin SL, Bernardo HT, Scussel R, et al. Weekly ethanol exposure alters dopaminergic parameters in zebrafish brain. Neurotoxicol Teratol. 2019;75:106822 https:\/\/doi.org\/10.1016\/j.ntt.2019.106822.","journal-title":"Neurotoxicol Teratol"},{"key":"3619_CR59","doi-asserted-by":"publisher","first-page":"e12847","DOI":"10.1111\/gbb.12847","volume":"22","author":"LB Kuiper","year":"2023","unstructured":"Kuiper LB, Roberts JB, Estave PM, Leo D, Gainetdinov RR, Jones SR. Patterns of ethanol intake in male rats with partial dopamine transporter deficiency. Genes Brain Behav. 2023;22:e12847 https:\/\/doi.org\/10.1111\/gbb.12847.","journal-title":"Genes Brain Behav"},{"key":"3619_CR60","doi-asserted-by":"publisher","first-page":"3145","DOI":"10.1007\/s00213-022-06195-5","volume":"239","author":"S Hussain","year":"2022","unstructured":"Hussain S, Lesscher HMD, Day DJ, Ellenbroek BA. Genetics and epigenetics: paternal adolescent ethanol consumption in serotonin transporter knock-out rats and offspring sensitivity to ethanol. Psychopharmacology. 2022;239:3145\u201359. https:\/\/doi.org\/10.1007\/s00213-022-06195-5.","journal-title":"Psychopharmacology"},{"key":"3619_CR61","doi-asserted-by":"publisher","first-page":"114308","DOI":"10.1016\/j.biopha.2023.114308","volume":"160","author":"H Wei","year":"2023","unstructured":"Wei H, Yu C, Zhang C, Ren Y, Guo L, Wang T, et al. Butyrate ameliorates chronic alcoholic central nervous damage by suppressing microglia-mediated neuroinflammation and modulating the microbiome-gut-brain axis. Biomed Pharmacother. 2023;160:114308 https:\/\/doi.org\/10.1016\/j.biopha.2023.114308.","journal-title":"Biomed Pharmacother"},{"key":"3619_CR62","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-018-1241-2","volume":"15","author":"K Zhang","year":"2018","unstructured":"Zhang K, Wang H, Xu M, Frank JA, Luo J. Role of MCP-1 and CCR2 in ethanol-induced neuroinflammation and neurodegeneration in the developing brain. J Neuroinflammation. 2018;15:197. https:\/\/doi.org\/10.1186\/s12974-018-1241-2.","journal-title":"J Neuroinflammation"},{"key":"3619_CR63","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.neuropharm.2017.11.019","volume":"129","author":"X Wang","year":"2018","unstructured":"Wang X, Zhang K, Yang F, Ren Z, Xu M, Frank JA, et al. Minocycline protects developing brain against ethanol-induced damage. Neuropharmacology. 2018;129:84\u201399. https:\/\/doi.org\/10.1016\/j.neuropharm.2017.11.019.","journal-title":"Neuropharmacology"},{"key":"3619_CR64","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.neuro.2017.04.005","volume":"60","author":"C Cruz","year":"2017","unstructured":"Cruz C, Meireles M, Silva SM. Chronic ethanol intake induces partial microglial activation that is not reversed by long-term ethanol withdrawal in the rat hippocampal formation. Neurotoxicology. 2017;60:107\u201315. https:\/\/doi.org\/10.1016\/j.neuro.2017.04.005.","journal-title":"Neurotoxicology"},{"key":"3619_CR65","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.neuropharm.2017.08.011","volume":"125","author":"DV Avila","year":"2017","unstructured":"Avila DV, Myers SA, Zhang J, Kharebava G, McClain CJ, Kim HY, et al. Phosphodiesterase 4b expression plays a major role in alcohol-induced neuro-inflammation. Neuropharmacology. 2017;125:376\u201385. https:\/\/doi.org\/10.1016\/j.neuropharm.2017.08.011.","journal-title":"Neuropharmacology"},{"key":"3619_CR66","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-019-1678-y","volume":"17","author":"LGJ Coleman","year":"2020","unstructured":"Coleman LGJ, Zou J, Crews FT. Microglial depletion and repopulation in brain slice culture normalizes sensitized proinflammatory signaling. J Neuroinflammation. 2020;17:27. https:\/\/doi.org\/10.1186\/s12974-019-1678-y.","journal-title":"J Neuroinflammation"},{"key":"3619_CR67","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1111\/bpa.12276","volume":"26","author":"CJ Wilhelm","year":"2016","unstructured":"Wilhelm CJ, Hashimoto JG, Roberts ML, Bloom SH, Andrew MR, Wiren KM. Astrocyte dysfunction induced by alcohol in females but not males. Brain Pathol Zur Switz. 2016;26:433\u201351. https:\/\/doi.org\/10.1111\/bpa.12276.","journal-title":"Brain Pathol Zur Switz"},{"key":"3619_CR68","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1248\/bpb.b23-00140","volume":"46","author":"H Hasegawa","year":"2023","unstructured":"Hasegawa H, Kondo M. Astrocytic responses to binge alcohol intake in the mouse hindbrain. Biol Pharm Bull. 2023;46:1194\u2013202. https:\/\/doi.org\/10.1248\/bpb.b23-00140.","journal-title":"Biol Pharm Bull"},{"key":"3619_CR69","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/S0065-1281(11)80187-X","volume":"97","author":"H Franke","year":"1995","unstructured":"Franke H. Influence of chronic alcohol treatment on the GFAP-immunoreactivity in astrocytes of the hippocampus in rats. Acta Histochem. 1995;97:263\u201371. https:\/\/doi.org\/10.1016\/S0065-1281(11)80187-X.","journal-title":"Acta Histochem"},{"key":"3619_CR70","doi-asserted-by":"publisher","first-page":"108272","DOI":"10.1016\/j.neuropharm.2020.108272","volume":"179","author":"LL Giacometti","year":"2020","unstructured":"Giacometti LL, Chandran K, Figueroa LA, Barker JM. Astrocyte modulation of extinction impairments in ethanol-dependent female mice. Neuropharmacology. 2020;179:108272 https:\/\/doi.org\/10.1016\/j.neuropharm.2020.108272.","journal-title":"Neuropharmacology"},{"key":"3619_CR71","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1093\/alcalc\/agl006","volume":"41","author":"JJ Miguel-Hidalgo","year":"2006","unstructured":"Miguel-Hidalgo JJ. Withdrawal from free-choice ethanol consumption results in increased packing density of glutamine synthetase-immunoreactive astrocytes in the prelimbic cortex of alcohol-preferring rats. Alcohol Alcohol Oxf Oxfs. 2006;41:379\u201385. https:\/\/doi.org\/10.1093\/alcalc\/agl006.","journal-title":"Alcohol Alcohol Oxf Oxfs"},{"key":"3619_CR72","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.expneurol.2006.03.001","volume":"200","author":"SG Evrard","year":"2006","unstructured":"Evrard SG, Duhalde-Vega M, Tagliaferro P, Mirochnic S, Caltana LR, Brusco A. A low chronic ethanol exposure induces morphological changes in the adolescent rat brain that are not fully recovered even after a long abstinence: an immunohistochemical study. Exp Neurol. 2006;200:438\u201359. https:\/\/doi.org\/10.1016\/j.expneurol.2006.03.001.","journal-title":"Exp Neurol"},{"key":"3619_CR73","doi-asserted-by":"publisher","first-page":"2316","DOI":"10.3390\/ijms21072316","volume":"21","author":"B Peng","year":"2020","unstructured":"Peng B, Yang Q, B Joshi R, Liu Y, Akbar M, Song BJ, et al. Role of alcohol drinking in Alzheimer\u2019s disease, Parkinson\u2019s disease, and amyotrophic lateral sclerosis. Int J Mol Sci. 2020;21:2316 https:\/\/doi.org\/10.3390\/ijms21072316.","journal-title":"Int J Mol Sci"},{"key":"3619_CR74","doi-asserted-by":"publisher","first-page":"9492","DOI":"10.3390\/ijms24119492","volume":"24","author":"DV Chandrashekar","year":"2023","unstructured":"Chandrashekar DV, Steinberg RA, Han D, Sumbria RK. Alcohol as a modifiable risk factor for Alzheimer\u2019s disease-evidence from experimental studies. Int J Mol Sci. 2023;24:9492 https:\/\/doi.org\/10.3390\/ijms24119492.","journal-title":"Int J Mol Sci"},{"key":"3619_CR75","doi-asserted-by":"publisher","first-page":"5000","DOI":"10.1007\/s12035-020-02075-1","volume":"57","author":"A Sharma","year":"2020","unstructured":"Sharma A, Brenner M, Wang P. Potential role of extracellular CIRP in alcohol-induced Alzheimer\u2019s disease. Mol Neurobiol. 2020;57:5000\u201310. https:\/\/doi.org\/10.1007\/s12035-020-02075-1.","journal-title":"Mol Neurobiol"},{"key":"3619_CR76","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1097\/WNR.0000000000001661","volume":"32","author":"C Jiang","year":"2021","unstructured":"Jiang C, Zhang Y, Tang X, Jing C, Qiu S, Li B, et al. IL-6 and IL-1\u03b2 upregulation and tau protein phosphorylation in response to chronic alcohol exposure in the mouse hippocampus. Neuroreport. 2021;32:851\u20137. https:\/\/doi.org\/10.1097\/WNR.0000000000001661.","journal-title":"Neuroreport"},{"key":"3619_CR77","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.alcohol.2022.07.007","volume":"103","author":"CS Bailey","year":"2022","unstructured":"Bailey CS, Jagielo-Miller JE, Keller PS, Glaser EP, Wilcox AL, Prendergast MA. Ethanol sustains phosphorylated tau protein in the cultured neonatal rat hippocampus: implications for fetal alcohol spectrum disorders. Alcohol Fayettev N. 2022;103:45\u201354. https:\/\/doi.org\/10.1016\/j.alcohol.2022.07.007.","journal-title":"Alcohol Fayettev N."},{"key":"3619_CR78","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1111\/acer.14554","volume":"45","author":"J Azuar","year":"2021","unstructured":"Azuar J, Bouaziz-Amar E, Cognat E, Dumurgier J, Clergue-Duval V, Barr\u00e9 T, et al. Cerebrospinal fluid biomarkers in patients with alcohol use disorder and persistent cognitive impairment. Alcohol Clin Exp Res. 2021;45:561\u20135. https:\/\/doi.org\/10.1111\/acer.14554.","journal-title":"Alcohol Clin Exp Res"},{"key":"3619_CR79","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/7849876","volume":"2019","author":"BS Kwon","year":"2019","unstructured":"Kwon BS, Kim JM, Park SK, Kang JY, Kang JE, Lee CJ, et al. Chronic alcohol exposure induced neuroapoptosis: diminishing effect of ethyl acetate fraction from Aralia elata. Oxid Med Cell Longev. 2019;2019:7849876. https:\/\/doi.org\/10.1155\/2019\/7849876.","journal-title":"Oxid Med Cell Longev"},{"key":"3619_CR80","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.3233\/JAD-221079","volume":"93","author":"BT Nallapu","year":"2023","unstructured":"Nallapu BT, Petersen KK, Lipton RB, Grober E, Sperling RA, Ezzati A. Association of alcohol consumption with cognition in older population: the A4 Study. J Alzheimers Dis JAD. 2023;93:1381\u201393. https:\/\/doi.org\/10.3233\/JAD-221079.","journal-title":"J Alzheimers Dis JAD"},{"key":"3619_CR81","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.neurobiolaging.2018.06.006","volume":"70","author":"G Rutigliano","year":"2018","unstructured":"Rutigliano G, Stazi M, Arancio O, Watterson DM, Origlia N. An isoform-selective p38\u03b1 mitogen-activated protein kinase inhibitor rescues early entorhinal cortex dysfunctions in a mouse model of Alzheimer\u2019s disease. Neurobiol Aging. 2018;70:86\u201391. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2018.06.006.","journal-title":"Neurobiol Aging"},{"key":"3619_CR82","doi-asserted-by":"publisher","first-page":"6114","DOI":"10.1080\/07391102.2021.1877197","volume":"40","author":"S Iqbal","year":"2022","unstructured":"Iqbal S, Potharaju R, Naveen S, Lokanath NK, Mohanakrishnan AK, Gunasekaran K. Design, crystal structure determination, molecular dynamic simulation and MMGBSA calculations of novel p38-alpha MAPK inhibitors for combating Alzheimer\u2019s disease. J Biomol Struct Dyn. 2022;40:6114\u201327. https:\/\/doi.org\/10.1080\/07391102.2021.1877197.","journal-title":"J Biomol Struct Dyn"},{"key":"3619_CR83","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.2217\/nnm-2018-0496","volume":"14","author":"\u00c1 Casadom\u00e9-Perales","year":"2019","unstructured":"Casadom\u00e9-Perales \u00c1, Matteis LD, Alleva M, Infantes-Rodr\u00edguez C, Palomares-P\u00e9rez I, Saito T, et al. Inhibition of p38 MAPK in the brain through nasal administration of p38 inhibitor loaded in chitosan nanocapsules. Nanomed. 2019;14:2409\u201322. https:\/\/doi.org\/10.2217\/nnm-2018-0496.","journal-title":"Nanomed"},{"key":"3619_CR84","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s13195-016-0221-y","volume":"8","author":"N Maphis","year":"2016","unstructured":"Maphis N, Jiang S, Xu G, Kokiko-Cochran ON, Roy SM, Van Eldik LJ, et al. Selective suppression of the \u03b1 isoform of p38 MAPK rescues late-stage tau pathology. Alzheimers Res Ther. 2016;8:54 https:\/\/doi.org\/10.1186\/s13195-016-0221-y.","journal-title":"Alzheimers Res Ther"},{"key":"3619_CR85","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.nbd.2011.07.005","volume":"44","author":"EJ Gong","year":"2011","unstructured":"Gong EJ, Park HR, Kim ME, Piao S, Lee E, Jo DG, et al. Morin attenuates tau hyperphosphorylation by inhibiting GSK3\u03b2. Neurobiol Dis. 2011;44:223\u201330. https:\/\/doi.org\/10.1016\/j.nbd.2011.07.005.","journal-title":"Neurobiol Dis"},{"key":"3619_CR86","doi-asserted-by":"publisher","DOI":"10.1038\/srep45701","volume":"7","author":"I Gameiro","year":"2017","unstructured":"Gameiro I, Michalska P, Tenti G, Cores \u00c1, Buendia I, Rojo AI, et al. Discovery of the first dual GSK3\u03b2 inhibitor\/Nrf2 inducer. A new multitarget therapeutic strategy for Alzheimer\u2019s disease. Sci Rep. 2017;7:45701. https:\/\/doi.org\/10.1038\/srep45701.","journal-title":"Sci Rep."},{"key":"3619_CR87","doi-asserted-by":"publisher","first-page":"e108645","DOI":"10.1371\/journal.pone.0108645","volume":"9","author":"ZP Xu","year":"2014","unstructured":"Xu ZP, Li L, Bao J, Wang ZH, Zeng J, Liu EJ, et al. Magnesium protects cognitive functions and synaptic plasticity in streptozotocin-induced sporadic Alzheimer\u2019s model. PLoS One. 2014;9:e108645 https:\/\/doi.org\/10.1371\/journal.pone.0108645.","journal-title":"PLoS One"},{"key":"3619_CR88","doi-asserted-by":"publisher","first-page":"110373","DOI":"10.1016\/j.biopha.2020.110373","volume":"129","author":"V Sharma","year":"2020","unstructured":"Sharma V, Kaur A, Singh TG. Counteracting role of nuclear factor erythroid 2-related factor 2 pathway in Alzheimer\u2019s disease. Biomed Pharmacother. 2020;129:110373 https:\/\/doi.org\/10.1016\/j.biopha.2020.110373.","journal-title":"Biomed Pharmacother"},{"key":"3619_CR89","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.2174\/1568026620666200607190951","volume":"20","author":"VV Kleandrova","year":"2020","unstructured":"Kleandrova VV, Speck-Planche A. PTML modeling for Alzheimer\u2019s disease: design and prediction of virtual multi-target inhibitors of GSK3B, HDAC1, and HDAC6. Curr Top Med Chem. 2020;20:1661\u201376. https:\/\/doi.org\/10.2174\/1568026620666200607190951.","journal-title":"Curr Top Med Chem"},{"key":"3619_CR90","doi-asserted-by":"publisher","first-page":"461","DOI":"10.4155\/fmc-2017-0172","volume":"10","author":"L Zaffaroni","year":"2018","unstructured":"Zaffaroni L, Peri F. Recent advances on Toll-like receptor 4 modulation: new therapeutic perspectives. Future Med Chem. 2018;10:461\u201376. https:\/\/doi.org\/10.4155\/fmc-2017-0172.","journal-title":"Future Med Chem"},{"key":"3619_CR91","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1021\/acs.jcim.7b00717","volume":"58","author":"X Zhang","year":"2018","unstructured":"Zhang X, Cui F, Chen H, Zhang T, Yang K, Wang Y, et al. Dissecting the innate immune recognition of opioid inactive isomer (+)-Naltrexone derived toll-like receptor 4 (TLR4) antagonists. J Chem Inf Model. 2018;58:816\u201325. https:\/\/doi.org\/10.1021\/acs.jcim.7b00717.","journal-title":"J Chem Inf Model"},{"key":"3619_CR92","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2020.104246","volume":"104","author":"JS Wu","year":"2020","unstructured":"Wu JS, Meng QY, Shi XH, Liu LX, Zhang ZK, Guan HS, et al. The oxygenated products of cryptotanshinone by biotransformation with Cunninghamella elegans exerting anti-neuroinflammatory effects by inhibiting TLR 4-mediated MAPK signaling pathway. Bioorganic Chem. 2020;104:104246. https:\/\/doi.org\/10.1016\/j.bioorg.2020.104246.","journal-title":"Bioorganic Chem"},{"key":"3619_CR93","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2021.105107","volume":"114","author":"S Wang","year":"2021","unstructured":"Wang S, Wang H, Lin C, Zhang T, Gao J, Wu S, et al. Structure-activity relationship study of dihydroartemisinin C-10 hemiacetal derivatives as toll-like receptor 4 antagonists. Bioorganic Chem. 2021;114:105107. https:\/\/doi.org\/10.1016\/j.bioorg.2021.105107.","journal-title":"Bioorganic Chem"},{"key":"3619_CR94","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/s41401-021-00764-8","volume":"43","author":"YL Zhang","year":"2022","unstructured":"Zhang YL, Zhang WX, Yan JQ, Tang YL, Jia WJ, Xu ZW, et al. Chalcone derivatives ameliorate lipopolysaccharide-induced acute lung injury and inflammation by targeting MD2. Acta Pharm Sin. 2022;43:76\u201385. https:\/\/doi.org\/10.1038\/s41401-021-00764-8.","journal-title":"Acta Pharm Sin"},{"key":"3619_CR95","doi-asserted-by":"publisher","first-page":"e70031","DOI":"10.1002\/ddr.70031","volume":"86","author":"SK Batin Rahaman","year":"2025","unstructured":"Batin Rahaman SK, Nandi SK, Mandal SK, Debnath U. Structural diversity and mutational challenges of toll-like receptor 4 antagonists as inflammatory pathway blocker. Drug Dev Res. 2025;86:e70031 https:\/\/doi.org\/10.1002\/ddr.70031.","journal-title":"Drug Dev Res"},{"key":"3619_CR96","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-37421-w","volume":"9","author":"F Cochet","year":"2019","unstructured":"Cochet F, Facchini FA, Zaffaroni L, Billod JM, Coelho H, Holgado A, et al. Novel carboxylate-based glycolipids: TLR4 antagonism, MD-2 binding and self-assembly properties. Sci Rep. 2019;9:919. https:\/\/doi.org\/10.1038\/s41598-018-37421-w.","journal-title":"Sci Rep."},{"key":"3619_CR97","doi-asserted-by":"publisher","first-page":"106332","DOI":"10.1016\/j.nbd.2023.106332","volume":"188","author":"MK Gautier","year":"2023","unstructured":"Gautier MK, Kelley CM, Lee SH, Alldred MJ, McDaid J, Mufson EJ, et al. Maternal choline supplementation protects against age-associated cholinergic and GABAergic basal forebrain neuron degeneration in the Ts65Dn mouse model of Down syndrome and Alzheimer\u2019s disease. Neurobiol Dis. 2023;188:106332 https:\/\/doi.org\/10.1016\/j.nbd.2023.106332.","journal-title":"Neurobiol Dis"},{"key":"3619_CR98","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-03802-y","volume":"9","author":"N Lozovaya","year":"2018","unstructured":"Lozovaya N, Eftekhari S, Cloarec R, Gouty-Colomer LA, Dufour A, Riffault B, et al. GABAergic inhibition in dual-transmission cholinergic and GABAergic striatal interneurons is abolished in Parkinson disease. Nat Commun. 2018;9:1422. https:\/\/doi.org\/10.1038\/s41467-018-03802-y.","journal-title":"Nat Commun"},{"key":"3619_CR99","doi-asserted-by":"publisher","first-page":"5267","DOI":"10.1113\/JP276710","volume":"596","author":"CV Turco","year":"2018","unstructured":"Turco CV, El-Sayes J, Locke MB, Chen R, Baker S, Nelson AJ. Effects of lorazepam and baclofen on short- and long-latency afferent inhibition. J Physiol. 2018;596:5267\u201380. https:\/\/doi.org\/10.1113\/JP276710.","journal-title":"J Physiol"},{"key":"3619_CR100","doi-asserted-by":"publisher","first-page":"e202420510","DOI":"10.1002\/anie.202420510","volume":"64","author":"D Panek","year":"2025","unstructured":"Panek D, Pasieka A, Jo\u0144czyk J, Gawli\u0144ska M, Zar\u0119ba P, Siwek A, et al. Multifunctional, fluorene-based modulator of cholinergic and GABAergic neurotransmission as a novel drug candidate for palliative treatment of Alzheimer\u2019s disease. Angew Chem Int Ed Engl. 2025;64:e202420510 https:\/\/doi.org\/10.1002\/anie.202420510.","journal-title":"Angew Chem Int Ed Engl"},{"key":"3619_CR101","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.brainres.2018.11.042","volume":"1707","author":"E Ambrad Giovannetti","year":"2019","unstructured":"Ambrad Giovannetti E, Fuhrmann M. Unsupervised excitation: GABAergic dysfunctions in Alzheimer\u2019s disease. Brain Res. 2019;1707:216\u201326. https:\/\/doi.org\/10.1016\/j.brainres.2018.11.042.","journal-title":"Brain Res"},{"key":"3619_CR102","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1097\/WNR.0000000000001671","volume":"32","author":"GV Beselia","year":"2021","unstructured":"Beselia GV, Chkhikvishvili NC, Burjanadze MA, Solomonia RO, Meparishvili M, Nozadze B, et al. Modulation of prefrontal cortex function by basal forebrain cholinergic and GABAergic neurons at the behavioral and molecular level. Neuroreport. 2021;32:882\u20137. https:\/\/doi.org\/10.1097\/WNR.0000000000001671.","journal-title":"Neuroreport"},{"key":"3619_CR103","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1111\/fcp.12955","volume":"38","author":"M Golmohammadi","year":"2024","unstructured":"Golmohammadi M, Mahmoudian M, Hasan EK, Alshahrani SH, Romero-Parra RM, Malviya J, et al. Neuroprotective effects of riluzole in Alzheimer\u2019s disease: a comprehensive review. Fundam Clin Pharm. 2024;38:225\u201337. https:\/\/doi.org\/10.1111\/fcp.12955.","journal-title":"Fundam Clin Pharm"},{"key":"3619_CR104","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-52539-4","volume":"15","author":"D Hollingworth","year":"2024","unstructured":"Hollingworth D, Thomas F, Page DA, Fouda MA, De Castro RLR, Sula A, et al. Structural basis for the rescue of hyperexcitable cells by the amyotrophic lateral sclerosis drug Riluzole. Nat Commun. 2024;15:8426. https:\/\/doi.org\/10.1038\/s41467-024-52539-4.","journal-title":"Nat Commun"},{"key":"3619_CR105","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.bbrc.2022.04.051","volume":"610","author":"K Saba","year":"2022","unstructured":"Saba K, Patel AB. Riluzole restores memory and brain energy metabolism in A\u03b2PP-PS1 mouse model of Alzheimer\u2019s disease. Biochem Biophys Res Commun. 2022;610:140\u20136. https:\/\/doi.org\/10.1016\/j.bbrc.2022.04.051.","journal-title":"Biochem Biophys Res Commun"},{"key":"3619_CR106","doi-asserted-by":"publisher","first-page":"79","DOI":"10.4155\/ppa-2023-0001","volume":"12","author":"RA Al-Horani","year":"2023","unstructured":"Al-Horani RA. Riluzole and its prodrugs for the treatment of Alzheimer\u2019s disease. Pharm Pat Anal. 2023;12:79\u201385. https:\/\/doi.org\/10.4155\/ppa-2023-0001.","journal-title":"Pharm Pat Anal"},{"key":"3619_CR107","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1111\/jnc.15238","volume":"156","author":"NV Gulyaeva","year":"2021","unstructured":"Gulyaeva NV. Hippocampal hyperglutamatergic signaling matters: early targeting glutamate neurotransmission as a preventive strategy in Alzheimer\u2019s disease: an editorial highlight for \u201cRiluzole attenuates glutamatergic tone and cognitive decline in A\u03b2PP\/PS1 mice\u201d on page 513. J Neurochem. 2021;156:399\u2013402. https:\/\/doi.org\/10.1111\/jnc.15238.","journal-title":"J Neurochem"},{"key":"3619_CR108","doi-asserted-by":"publisher","first-page":"101273","DOI":"10.1016\/j.arr.2021.101273","volume":"67","author":"EJ Calabrese","year":"2021","unstructured":"Calabrese EJ, Calabrese V, Giordano J. Demonstrated hormetic mechanisms putatively subserve riluzole-induced effects in neuroprotection against amyotrophic lateral sclerosis (ALS): implications for research and clinical practice. Ageing Res Rev. 2021;67:101273 https:\/\/doi.org\/10.1016\/j.arr.2021.101273.","journal-title":"Ageing Res Rev"},{"key":"3619_CR109","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.25122\/jml-2023-0459","volume":"16","author":"AJ Firstenfeld","year":"2023","unstructured":"Firstenfeld AJ, Listorti J, Jalaff N, Loaiza Orozco CP, Navarrete Gosdenovich F, Schurr T. Add-on treatment with cerebrolysin improves clinical symptoms in patients with ALS: results from a prospective, single-center, placebo-controlled, randomized, double-blind, phase II study. J Med Life. 2023;16:1750\u20135. https:\/\/doi.org\/10.25122\/jml-2023-0459.","journal-title":"J Med Life"},{"key":"3619_CR110","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-024-05507-x","volume":"22","author":"F Rwere","year":"2024","unstructured":"Rwere F, White JR, Hell RCR, Yu X, Zeng X, McNeil L, et al. Uncovering newly identified aldehyde dehydrogenase 2 genetic variants that lead to acetaldehyde accumulation after an alcohol challenge. J Transl Med. 2024;22:697. https:\/\/doi.org\/10.1186\/s12967-024-05507-x.","journal-title":"J Transl Med"},{"key":"3619_CR111","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/s42255-021-00357-z","volume":"3","author":"S Jin","year":"2021","unstructured":"Jin S, Cao Q, Yang F, Zhu H, Xu S, Chen Q, et al. Brain ethanol metabolism by astrocytic ALDH2 drives the behavioural effects of ethanol intoxication. Nat Metab. 2021;3:337\u201351. https:\/\/doi.org\/10.1038\/s42255-021-00357-z.","journal-title":"Nat Metab"},{"key":"3619_CR112","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.jcmgh.2022.10.002","volume":"15","author":"SH Park","year":"2023","unstructured":"Park SH, Seo W, Xu MJ, Mackowiak B, Lin Y, He Y, et al. Ethanol and its nonoxidative metabolites promote acute liver injury by inducing ER stress, adipocyte death, and lipolysis. Cell Mol Gastroenterol Hepatol. 2023;15:281\u2013306. https:\/\/doi.org\/10.1016\/j.jcmgh.2022.10.002.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"3619_CR113","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2024.122508","volume":"343","author":"Q Lu","year":"2024","unstructured":"Lu Q, Qin X, Chen C, Yu W, Lin J, Liu X, et al. Elevated levels of alcohol dehydrogenase aggravate ethanol-evoked cardiac remodeling and contractile anomalies through FKBP5-yap-mediated regulation of ferroptosis and ER stress. Life Sci. 2024;343:122508. https:\/\/doi.org\/10.1016\/j.lfs.2024.122508.","journal-title":"Life Sci"},{"key":"3619_CR114","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.13252","volume":"55","author":"X Lin","year":"2022","unstructured":"Lin X, Zhu D, Wang K, Luo P, Rui G, Gao Y, et al. Activation of aldehyde dehydrogenase 2 protects ethanol-induced osteonecrosis of the femoral head in rat model. Cell Prolif. 2022;55:e13252. https:\/\/doi.org\/10.1111\/cpr.13252.","journal-title":"Cell Prolif"},{"key":"3619_CR115","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1093\/bbb\/zbae100","volume":"88","author":"Y Xu","year":"2024","unstructured":"Xu Y, Sawamoto T, Sun R, Ishikura A, Munemasa S, Murata Y, et al. Evaluation of quercetin as a potential cytoprotector against acetaldehyde using the cultured hepatocyte model with aldehyde dehydrogenase isozyme deficiency. Biosci Biotechnol Biochem. 2024;88:1199\u2013202. https:\/\/doi.org\/10.1093\/bbb\/zbae100.","journal-title":"Biosci Biotechnol Biochem"},{"key":"3619_CR116","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1038\/s42255-024-01063-2","volume":"6","author":"Y Fu","year":"2024","unstructured":"Fu Y, Mackowiak B, Lin YH, Maccioni L, Lehner T, Pan H, et al. Coordinated action of a gut-liver pathway drives alcohol detoxification and consumption. Nat Metab. 2024;6:1380\u201396. https:\/\/doi.org\/10.1038\/s42255-024-01063-2.","journal-title":"Nat Metab"},{"key":"3619_CR117","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.3390\/nu13061875","volume":"13","author":"SJ Jung","year":"2021","unstructured":"Jung SJ, Hwang JH, Park EO, Lee SO, Chung YJ, Chung MJ, et al. Regulation of alcohol and acetaldehyde metabolism by a mixture of Lactobacillus and Bifidobacterium species in human. Nutrients. 2021;13:1875 https:\/\/doi.org\/10.3390\/nu13061875.","journal-title":"Nutrients"},{"key":"3619_CR118","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1093\/carcin\/bgad085","volume":"45","author":"S Flashner","year":"2024","unstructured":"Flashner S, Shimonosono M, Tomita Y, Matsuura N, Ohashi S, Muto M, et al. ALDH2 dysfunction and alcohol cooperate in cancer stem cell enrichment. Carcinogenesis. 2024;45:95\u2013106. https:\/\/doi.org\/10.1093\/carcin\/bgad085.","journal-title":"Carcinogenesis"},{"key":"3619_CR119","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1007\/s00018-023-05061-7","volume":"81","author":"KR LeFort","year":"2024","unstructured":"LeFort KR, Rungratanawanich W, Song BJ. Contributing roles of mitochondrial dysfunction and hepatocyte apoptosis in liver diseases through oxidative stress, post-translational modifications, inflammation, and intestinal barrier dysfunction. Cell Mol Life Sci. 2024;81:34 https:\/\/doi.org\/10.1007\/s00018-023-05061-7.","journal-title":"Cell Mol Life Sci"},{"key":"3619_CR120","doi-asserted-by":"publisher","first-page":"agad077","DOI":"10.1093\/alcalc\/agad077","volume":"59","author":"T Lehner","year":"2024","unstructured":"Lehner T, Gao B, Mackowiak B. Alcohol metabolism in alcohol use disorder: a potential therapeutic target. Alcohol Alcohol Oxf Oxfs. 2024;59:agad077 https:\/\/doi.org\/10.1093\/alcalc\/agad077.","journal-title":"Alcohol Alcohol Oxf Oxfs"},{"key":"3619_CR121","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1111\/acer.15273","volume":"48","author":"J Aguilar","year":"2024","unstructured":"Aguilar J, De Carvalho LM, Chen H, Condon R, Lasek AW, Pradhan AA. Histone deacetylase inhibitor decreases hyperalgesia in a mouse model of alcohol withdrawal-induced hyperalgesia. Alcohol Clin Exp Res. 2024;48:478\u201387. https:\/\/doi.org\/10.1111\/acer.15273.","journal-title":"Alcohol Clin Exp Res"},{"key":"3619_CR122","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.nbd.2015.03.019","volume":"82","author":"SC Pandey","year":"2015","unstructured":"Pandey SC, Sakharkar AJ, Tang L, Zhang H. Potential role of adolescent alcohol exposure-induced amygdaloid histone modifications in anxiety and alcohol intake during adulthood. Neurobiol Dis. 2015;82:607\u201319. https:\/\/doi.org\/10.1016\/j.nbd.2015.03.019.","journal-title":"Neurobiol Dis"},{"key":"3619_CR123","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1111\/acer.12172","volume":"37","author":"I Kirpich","year":"2013","unstructured":"Kirpich I, Zhang J, Gobejishvili L, Kharebava G, Barker D, Ghare S, et al. Binge ethanol-induced HDAC3 down-regulates Cpt1\u03b1 expression leading to hepatic steatosis and injury. Alcohol Clin Exp Res. 2013;37:1920\u20139. https:\/\/doi.org\/10.1111\/acer.12172.","journal-title":"Alcohol Clin Exp Res"},{"key":"3619_CR124","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.jcmgh.2019.10.005","volume":"9","author":"H Donde","year":"2020","unstructured":"Donde H, Ghare S, Joshi-Barve S, Zhang J, Vadhanam MV, Gobejishvili L, et al. Tributyrin inhibits ethanol-induced epigenetic repression of CPT-1A and attenuates hepatic steatosis and injury. Cell Mol Gastroenterol Hepatol. 2020;9:569\u201385. https:\/\/doi.org\/10.1016\/j.jcmgh.2019.10.005.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"3619_CR125","doi-asserted-by":"publisher","DOI":"10.1111\/adb.12760","volume":"25","author":"I Drissi","year":"2020","unstructured":"Drissi I, Deschamps C, Fouquet G, Alary R, Peineau S, Gosset P, et al. Memory and plasticity impairment after binge drinking in adolescent rat hippocampus: GluN2A\/GluN2B NMDA receptor subunits imbalance through HDAC2. Addict Biol. 2020;25:e12760. https:\/\/doi.org\/10.1111\/adb.12760.","journal-title":"Addict Biol"},{"key":"3619_CR126","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1111\/j.1530-0277.2011.01492.x","volume":"35","author":"M Agudelo","year":"2011","unstructured":"Agudelo M, Gandhi N, Saiyed Z, Pichili V, Thangavel S, Khatavkar P, et al. Effects of alcohol on histone deacetylase 2 (HDAC2) and the neuroprotective role of trichostatin A (TSA). Alcohol Clin Exp Res. 2011;35:1550\u20136. https:\/\/doi.org\/10.1111\/j.1530-0277.2011.01492.x.","journal-title":"Alcohol Clin Exp Res"},{"key":"3619_CR127","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.alcohol.2017.01.016","volume":"60","author":"I Ponomarev","year":"2017","unstructured":"Ponomarev I, Stelly CE, Morikawa H, Blednov YA, Mayfield RD, Harris RA. Mechanistic insights into epigenetic modulation of ethanol consumption. Alcohol Fayettev N. 2017;60:95\u2013101. https:\/\/doi.org\/10.1016\/j.alcohol.2017.01.016.","journal-title":"Alcohol Fayettev N."},{"key":"3619_CR128","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4331\/wjbc.v6.i1.1","volume":"6","author":"JY Kim","year":"2015","unstructured":"Kim JY, Lee DY, Lee YJ, Park KJ, Kim KH, Kim JW, et al. Chronic alcohol consumption potentiates the development of diabetes through pancreatic \u03b2-cell dysfunction. World J Biol Chem. 2015;6:1\u201315. https:\/\/doi.org\/10.4331\/wjbc.v6.i1.1.","journal-title":"World J Biol Chem"},{"key":"3619_CR129","doi-asserted-by":"publisher","first-page":"18742","DOI":"10.1074\/jbc.M109.011015","volume":"284","author":"WQ Zhao","year":"2009","unstructured":"Zhao WQ, Lacor PN, Chen H, Lambert MP, Quon MJ, Krafft GA, et al. Insulin receptor dysfunction impairs cellular clearance of neurotoxic oligomeric a{beta}. J Biol Chem. 2009;284:18742\u201353. https:\/\/doi.org\/10.1074\/jbc.M109.011015.","journal-title":"J Biol Chem"},{"key":"3619_CR130","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1016\/S1474-4422(20)30231-3","volume":"19","author":"D Kellar","year":"2020","unstructured":"Kellar D, Craft S. Brain insulin resistance in Alzheimer\u2019s disease and related disorders: mechanisms and therapeutic approaches. Lancet Neurol. 2020;19:758\u201366. https:\/\/doi.org\/10.1016\/S1474-4422(20)30231-3.","journal-title":"Lancet Neurol"},{"key":"3619_CR131","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1172\/JCI59903","volume":"122","author":"K Talbot","year":"2012","unstructured":"Talbot K, Wang HY, Kazi H, Han LY, Bakshi KP, Stucky A, et al. Demonstrated brain insulin resistance in Alzheimer\u2019s disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline. J Clin Invest. 2012;122:1316\u201338. https:\/\/doi.org\/10.1172\/JCI59903.","journal-title":"J Clin Invest"},{"key":"3619_CR132","doi-asserted-by":"publisher","first-page":"9078","DOI":"10.1523\/JNEUROSCI.1071-09.2009","volume":"29","author":"QL Ma","year":"2009","unstructured":"Ma QL, Yang F, Rosario ER, Ubeda OJ, Beech W, Gant DJ, et al. Beta-amyloid oligomers induce phosphorylation of tau and inactivation of insulin receptor substrate via c-Jun N-terminal kinase signaling: suppression by omega-3 fatty acids and curcumin. J Neurosci. 2009;29:9078\u201389. https:\/\/doi.org\/10.1523\/JNEUROSCI.1071-09.2009.","journal-title":"J Neurosci"},{"key":"3619_CR133","doi-asserted-by":"publisher","first-page":"e163266","DOI":"10.1172\/JCI163266","volume":"133","author":"Y Zhu","year":"2023","unstructured":"Zhu Y, Wang K, Ma T, Ji Y, Lou Y, Fu X, et al. Nucleus accumbens D1\/D2 circuits control opioid withdrawal symptoms in mice. J Clin Invest. 2023;133:e163266 https:\/\/doi.org\/10.1172\/JCI163266.","journal-title":"J Clin Invest"},{"key":"3619_CR134","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1523\/JNEUROSCI.1377-18.2018","volume":"39","author":"C Cannizzaro","year":"2019","unstructured":"Cannizzaro C, Talani G, Brancato A, Mulas G, Spiga S, De Luca MA, et al. Dopamine Restores Limbic Memory Loss, Dendritic Spine Structure, and NMDAR-Dependent LTD in the Nucleus Accumbens of Alcohol-Withdrawn Rats. J Neurosci. 2019;39:929\u201343. https:\/\/doi.org\/10.1523\/JNEUROSCI.1377-18.2018.","journal-title":"J Neurosci"},{"key":"3619_CR135","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1038\/s41386-018-0102-0","volume":"43","author":"O Vranjkovic","year":"2018","unstructured":"Vranjkovic O, Winkler G, Winder DG. Ketamine administration during a critical period after forced ethanol abstinence inhibits the development of time-dependent affective disturbances. Neuropsychopharmacol. 2018;43:1915\u201323. https:\/\/doi.org\/10.1038\/s41386-018-0102-0.","journal-title":"Neuropsychopharmacol"},{"key":"3619_CR136","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.biopsych.2016.07.007","volume":"81","author":"R Saravia","year":"2017","unstructured":"Saravia R, Flores \u00c1, Plaza-Zabala A, Busquets-Garcia A, Pastor A, de la Torre R, et al. CB(1) Cannabinoid receptors mediate cognitive deficits and structural plasticity changes during nicotine withdrawal. Biol Psychiatry. 2017;81:625\u201334. https:\/\/doi.org\/10.1016\/j.biopsych.2016.07.007.","journal-title":"Biol Psychiatry"},{"key":"3619_CR137","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1001\/jamapsychiatry.2014.352","volume":"71","author":"S K\u00fchn","year":"2014","unstructured":"K\u00fchn S, Charlet K, Schubert F, Kiefer F, Zimmermann P, Heinz A, et al. Plasticity of hippocampal subfield volume cornu ammonis 2+3 over the course of withdrawal in patients with alcohol dependence. JAMA Psychiatry. 2014;71:806\u201311. https:\/\/doi.org\/10.1001\/jamapsychiatry.2014.352.","journal-title":"JAMA Psychiatry"},{"key":"3619_CR138","doi-asserted-by":"publisher","first-page":"e12715","DOI":"10.1111\/adb.12715","volume":"25","author":"BS Go","year":"2020","unstructured":"Go BS, Sirohi S, Walker BM. The role of matrix metalloproteinase-9 in negative reinforcement learning and plasticity in alcohol dependence. Addict Biol. 2020;25:e12715 https:\/\/doi.org\/10.1111\/adb.12715.","journal-title":"Addict Biol"},{"key":"3619_CR139","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s00702-023-02678-7","volume":"131","author":"O Lagstr\u00f6m","year":"2024","unstructured":"Lagstr\u00f6m O, Vestin E, S\u00f6derpalm B, Ericson M, Adermark L. Subregion specific neuroadaptations in the female rat striatum during acute and protracted withdrawal from nicotine. J Neural Transm. 2024;131:83\u201394. https:\/\/doi.org\/10.1007\/s00702-023-02678-7.","journal-title":"J Neural Transm"},{"key":"3619_CR140","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1097\/MOL.0000000000000862","volume":"34","author":"FK Welty","year":"2023","unstructured":"Welty FK. Omega-3 fatty acids and cognitive function. Curr Opin Lipido. 2023;34:12\u201321. https:\/\/doi.org\/10.1097\/MOL.0000000000000862.","journal-title":"Curr Opin Lipido"},{"key":"3619_CR141","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1016\/j.ajcnut.2023.04.001","volume":"117","author":"BZ Wei","year":"2023","unstructured":"Wei BZ, Li L, Dong CW, Tan CC, Xu W. The relationship of Omega-3 fatty acids with dementia and cognitive decline: evidence from prospective cohort studies of supplementation, dietary intake, and blood markers. Am J Clin Nutr. 2023;117:1096\u2013109. https:\/\/doi.org\/10.1016\/j.ajcnut.2023.04.001.","journal-title":"Am J Clin Nutr"},{"key":"3619_CR142","doi-asserted-by":"publisher","first-page":"S455","DOI":"10.3233\/JAD-231467","volume":"101","author":"HN Yassine","year":"2024","unstructured":"Yassine HN, Carrasco AS, Badie DS. Designing newer Omega-3 supplementation trials for cognitive outcomes: a systematic review guided analysis. J Alzheimers Dis JAD. 2024;101:S455\u2013S466. https:\/\/doi.org\/10.3233\/JAD-231467.","journal-title":"J Alzheimers Dis JAD"},{"key":"3619_CR143","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1016\/j.ajcnut.2024.01.020","volume":"119","author":"LJ Chen","year":"2024","unstructured":"Chen LJ, Sha S, Stocker H, Brenner H, Sch\u00f6ttker B. The associations of serum vitamin D status and vitamin D supplements use with all-cause dementia, Alzheimer\u2019s disease, and vascular dementia: a UK Biobank based prospective cohort study. Am J Clin Nutr. 2024;119:1052\u201364. https:\/\/doi.org\/10.1016\/j.ajcnut.2024.01.020.","journal-title":"Am J Clin Nutr"},{"key":"3619_CR144","doi-asserted-by":"publisher","first-page":"e638","DOI":"10.1097\/MJT.0000000000001302","volume":"28","author":"Y Du","year":"2020","unstructured":"Du Y, Liang F, Zhang L, Liu J, Dou H. Vitamin D supplement for prevention of Alzheimer\u2019s disease: a systematic review and meta-analysis. Am J Ther. 2020;28:e638\u2013e648. https:\/\/doi.org\/10.1097\/MJT.0000000000001302.","journal-title":"Am J Ther"},{"key":"3619_CR145","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.3390\/nu12041032","volume":"12","author":"RN Thota","year":"2020","unstructured":"Thota RN, Rosato JI, Dias CB, Burrows TL, Martins RN, Garg ML. Dietary supplementation with curcumin reduce circulating levels of glycogen synthase kinase-3\u03b2 and islet amyloid polypeptide in adults with high risk of type 2 diabetes and Alzheimer\u2019s disease. Nutrients. 2020;12:1032 https:\/\/doi.org\/10.3390\/nu12041032.","journal-title":"Nutrients"},{"key":"3619_CR146","doi-asserted-by":"publisher","first-page":"190.e1","DOI":"10.1016\/j.ajem.2024.09.058","volume":"86","author":"S Patel","year":"2024","unstructured":"Patel S, Lambert K. Marchiafava Bignami disease presenting as a cerebrovascular accident. Am J Emerg Med. 2024;86:190.e1\u2013190.e3. https:\/\/doi.org\/10.1016\/j.ajem.2024.09.058.","journal-title":"Am J Emerg Med"},{"key":"3619_CR147","doi-asserted-by":"publisher","first-page":"550","DOI":"10.3390\/nu12020550","volume":"12","author":"A Chauhan","year":"2020","unstructured":"Chauhan A, Chauhan V. Beneficial effects of walnuts on cognition and brain health. Nutrients. 2020;12:550 https:\/\/doi.org\/10.3390\/nu12020550.","journal-title":"Nutrients"},{"key":"3619_CR148","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.1007\/s11064-010-0307-z","volume":"35","author":"V Calabrese","year":"2010","unstructured":"Calabrese V, Cornelius C, Stella AMG, Calabrese EJ. Cellular stress responses, mitostress and carnitine insufficiencies as critical determinants in aging and neurodegenerative disorders: role of hormesis and vitagenes. Neurochem Res. 2010;35:1880\u2013915. https:\/\/doi.org\/10.1007\/s11064-010-0307-z.","journal-title":"Neurochem Res"},{"key":"3619_CR149","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1006\/bbrc.2000.2311","volume":"269","author":"V Calabrese","year":"2000","unstructured":"Calabrese V, Testa G, Ravagna A, Bates TE, Stella AM. HSP70 induction in the brain following ethanol administration in the rat: regulation by glutathione redox state. Biochem Biophys Res Commun. 2000;269:397\u2013400. https:\/\/doi.org\/10.1006\/bbrc.2000.2311.","journal-title":"Biochem Biophys Res Commun"},{"key":"3619_CR150","doi-asserted-by":"publisher","first-page":"113320","DOI":"10.1016\/j.ejmech.2021.113320","volume":"216","author":"S Srivastava","year":"2021","unstructured":"Srivastava S, Ahmad R, Khare SK. Alzheimer\u2019s disease and its treatment by different approaches: a review. Eur J Med Chem. 2021;216:113320 https:\/\/doi.org\/10.1016\/j.ejmech.2021.113320.","journal-title":"Eur J Med Chem"},{"key":"3619_CR151","doi-asserted-by":"publisher","first-page":"5085","DOI":"10.1039\/d4tb00521j","volume":"12","author":"A Vargas-Barona","year":"2024","unstructured":"Vargas-Barona A, Bern\u00e1ldez-Sarabia J, Castro-Cese\u00f1a AB. Lipid-polymer hybrid nanoparticles loaded with N-acetylcysteine for the modulation of neuroinflammatory biomarkers in human iPSC-derived PSEN2 (N141I) astrocytes as a model of Alzheimer\u2019s disease. J Mater Chem B. 2024;12:5085\u201397. https:\/\/doi.org\/10.1039\/d4tb00521j.","journal-title":"J Mater Chem B"},{"key":"3619_CR152","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1615\/CritRevBiomedEng.2020034302","volume":"48","author":"A Singh","year":"2020","unstructured":"Singh A, Mahajan SD, Kutscher HL, Kim S, Prasad PN. Curcumin-pluronic nanoparticles: a theranostic nanoformulation for Alzheimer\u2019s disease. Crit Rev Biomed Eng. 2020;48:153\u201368. https:\/\/doi.org\/10.1615\/CritRevBiomedEng.2020034302.","journal-title":"Crit Rev Biomed Eng"},{"key":"3619_CR153","doi-asserted-by":"publisher","first-page":"55879","DOI":"10.1021\/acsami.1c17267","volume":"13","author":"W Wang","year":"2021","unstructured":"Wang W, Liu M, Gao W, Sun Y, Dong X. Coassembled chitosan-hyaluronic acid nanoparticles as a theranostic agent targeting Alzheimer\u2019s \u03b2-Amyloid. ACS Appl Mater Interfaces. 2021;13:55879\u201389. https:\/\/doi.org\/10.1021\/acsami.1c17267.","journal-title":"ACS Appl Mater Interfaces"},{"key":"3619_CR154","doi-asserted-by":"publisher","first-page":"2268","DOI":"10.7150\/thno.30649","volume":"9","author":"D Liu","year":"2019","unstructured":"Liu D, Li W, Jiang X, Bai S, Liu J, Liu X, et al. Using near-infrared enhanced thermozyme and scFv dual-conjugated Au nanorods for detection and targeted photothermal treatment of Alzheimer\u2019s disease. Theranostics. 2019;9:2268\u201381. https:\/\/doi.org\/10.7150\/thno.30649.","journal-title":"Theranostics"},{"key":"3619_CR155","doi-asserted-by":"publisher","first-page":"10031","DOI":"10.1007\/s00210-024-03253-x","volume":"397","author":"SK Kushawaha","year":"2024","unstructured":"Kushawaha SK, Ashawat MS, Baldi A. Auranofin-loaded PLGA nanoparticles alleviate cognitive deficit induced by streptozotocin in rats model: modulation of oxidative stress, neuroinflammatory markers, and neurotransmitters. Naunyn Schmiedebergs Arch Pharm. 2024;397:10031\u201347. https:\/\/doi.org\/10.1007\/s00210-024-03253-x.","journal-title":"Naunyn Schmiedebergs Arch Pharm"},{"key":"3619_CR156","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s12951-021-00864-x","volume":"19","author":"A Cano","year":"2021","unstructured":"Cano A, Turowski P, Ettcheto M, Duskey JT, Tosi G, S\u00e1nchez-L\u00f3pez E, et al. Nanomedicine-based technologies and novel biomarkers for the diagnosis and treatment of Alzheimer\u2019s disease: from current to future challenges. J Nanobiotechnol. 2021;19:122 https:\/\/doi.org\/10.1186\/s12951-021-00864-x.","journal-title":"J Nanobiotechnol"},{"key":"3619_CR157","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.jpsychires.2024.09.022","volume":"179","author":"S Aminyavari","year":"2024","unstructured":"Aminyavari S, Afshari AR, Ahmadi SS, Kesharwani P, Sanati M, Sahebkar A. Unveiling the theranostic potential of SPIONs in Alzheimer\u2019s disease management. J Psychiatr Res. 2024;179:244\u201356. https:\/\/doi.org\/10.1016\/j.jpsychires.2024.09.022.","journal-title":"J Psychiatr Res"},{"key":"3619_CR158","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1186\/s12951-024-02526-0","volume":"22","author":"A Tapia-Arellano","year":"2024","unstructured":"Tapia-Arellano A, Cabrera P, Cort\u00e9s-Adasme E, Riveros A, Hassan N, Kogan MJ. Tau- and \u03b1-synuclein-targeted gold nanoparticles: applications, opportunities, and future outlooks in the diagnosis and therapy of neurodegenerative diseases. J Nanobiotechnol. 2024;22:248 https:\/\/doi.org\/10.1186\/s12951-024-02526-0.","journal-title":"J Nanobiotechnol"},{"key":"3619_CR159","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.2174\/1389203721666200226101930","volume":"21","author":"S Shaikh","year":"2020","unstructured":"Shaikh S, Nazam N, Danish Rizvi SM, Hussain T, Farhana A, Choi I. Anti-Amyloid aggregating gold nanoparticles: can they really be translated from bench to bedside for Alzheimer\u2019s disease treatment?. Curr Protein Pept Sci. 2020;21:1184\u201392. https:\/\/doi.org\/10.2174\/1389203721666200226101930.","journal-title":"Curr Protein Pept Sci"},{"key":"3619_CR160","doi-asserted-by":"publisher","first-page":"5298","DOI":"10.1021\/acs.jmedchem.9b00058","volume":"62","author":"SM Roy","year":"2019","unstructured":"Roy SM, Minasov G, Arancio O, Chico LW, Van Eldik LJ, Anderson WF, et al. A selective and brain penetrant p38\u03b1MAPK inhibitor candidate for neurologic and neuropsychiatric disorders that attenuates neuroinflammation and cognitive dysfunction. J Med Chem. 2019;62:5298\u2013311. https:\/\/doi.org\/10.1021\/acs.jmedchem.9b00058.","journal-title":"J Med Chem"},{"key":"3619_CR161","doi-asserted-by":"publisher","first-page":"E10245","DOI":"10.1073\/pnas.1809137115","volume":"115","author":"MJ Robson","year":"2018","unstructured":"Robson MJ, Quinlan MA, Margolis KG, Gajewski-Kurdziel PA, Veenstra-VanderWeele J, Gershon MD, et al. p38\u03b1 MAPK signaling drives pharmacologically reversible brain and gastrointestinal phenotypes in the SERT Ala56 mouse. Proc Natl Acad Sci USA. 2018;115:E10245\u2013E10254. https:\/\/doi.org\/10.1073\/pnas.1809137115.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3619_CR162","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1021\/acschemneuro.5b00002","volume":"6","author":"SM Roy","year":"2015","unstructured":"Roy SM, Grum-Tokars VL, Schavocky JP, Saeed F, Staniszewski A, Teich AF, et al. Targeting human central nervous system protein kinases: an isoform selective p38\u03b1MAPK inhibitor that attenuates disease progression in Alzheimer\u2019s disease mouse models. ACS Chem Neurosci. 2015;6:666\u201380. https:\/\/doi.org\/10.1021\/acschemneuro.5b00002.","journal-title":"ACS Chem Neurosci"},{"key":"3619_CR163","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-017-0845-2","volume":"14","author":"Z Zhou","year":"2017","unstructured":"Zhou Z, Bachstetter AD, Sp\u00e4ni CB, Roy SM, Watterson DM, Van Eldik LJ. Retention of normal glia function by an isoform-selective protein kinase inhibitor drug candidate that modulates cytokine production and cognitive outcomes. J Neuroinflammation. 2017;14:75. https:\/\/doi.org\/10.1186\/s12974-017-0845-2.","journal-title":"J Neuroinflammation"},{"key":"3619_CR164","doi-asserted-by":"publisher","first-page":"104279","DOI":"10.1016\/j.bioorg.2020.104279","volume":"104","author":"E Akin Kazancioglu","year":"2020","unstructured":"Akin Kazancioglu E, Senturk M. Synthesis of N-phenylsulfonamide derivatives and investigation of some esterase enzymes inhibiting properties. Bioorganic Chem. 2020;104:104279 https:\/\/doi.org\/10.1016\/j.bioorg.2020.104279.","journal-title":"Bioorganic Chem"},{"key":"3619_CR165","doi-asserted-by":"publisher","first-page":"7380","DOI":"10.1021\/acs.jmedchem.2c00457","volume":"65","author":"N Georgakopoulos","year":"2022","unstructured":"Georgakopoulos N, Talapatra S, Dikovskaya D, Dayalan Naidu S, Higgins M, Gatliff J, et al. Phenyl Bis-Sulfonamide Keap1-Nrf2 protein-protein interaction inhibitors with an alternative binding mode. J Med Chem. 2022;65:7380\u201398. https:\/\/doi.org\/10.1021\/acs.jmedchem.2c00457.","journal-title":"J Med Chem"},{"key":"3619_CR166","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2021.113224","volume":"215","author":"S Manzoor","year":"2021","unstructured":"Manzoor S, Prajapati SK, Majumdar S, Raza MK, Gabr MT, Kumar S, et al. Discovery of new phenyl sulfonyl-pyrimidine carboxylate derivatives as the potential multi-target drugs with effective anti-Alzheimer\u2019s action: design, synthesis, crystal structure and in-vitro biological evaluation. Eur J Med Chem. 2021;215:113224. https:\/\/doi.org\/10.1016\/j.ejmech.2021.113224.","journal-title":"Eur J Med Chem"},{"key":"3619_CR167","doi-asserted-by":"publisher","first-page":"4066","DOI":"10.1016\/j.bmcl.2011.04.121","volume":"21","author":"SR Selness","year":"2011","unstructured":"Selness SR, Devraj RV, Devadas B, Walker JK, Boehm TL, Durley RC, et al. Discovery of PH-797804, a highly selective and potent inhibitor of p38 MAP kinase. Bioorg Med Chem Lett. 2011;21:4066\u201371. https:\/\/doi.org\/10.1016\/j.bmcl.2011.04.121.","journal-title":"Bioorg Med Chem Lett"},{"key":"3619_CR168","doi-asserted-by":"publisher","first-page":"201","DOI":"10.4155\/fmc-2017-0126","volume":"10","author":"HM Hashem","year":"2018","unstructured":"Hashem HM, Mahrouse MA. In vitro metabolism study of a novel P38 kinase inhibitor: in silico predictions, structure elucidation using MS\/MS-I. Future Med Chem. 2018;10:201\u201320. https:\/\/doi.org\/10.4155\/fmc-2017-0126.","journal-title":"Future Med Chem"},{"key":"3619_CR169","doi-asserted-by":"publisher","first-page":"6402","DOI":"10.1021\/bi900655f","volume":"48","author":"L Xing","year":"2009","unstructured":"Xing L, Shieh HS, Selness SR, Devraj RV, Walker JK, Devadas B, et al. Structural bioinformatics-based prediction of exceptional selectivity of p38 MAP kinase inhibitor PH-797804. Biochemistry. 2009;48:6402\u201311. https:\/\/doi.org\/10.1021\/bi900655f.","journal-title":"Biochemistry"},{"key":"3619_CR170","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1002\/cmdc.201100439","volume":"7","author":"L Xing","year":"2012","unstructured":"Xing L, Devadas B, Devraj RV, Selness SR, Shieh H, Walker JK, et al. Discovery and characterization of atropisomer PH-797804, a p38 MAP kinase inhibitor, as a clinical drug candidate. ChemMedChem. 2012;7:273\u201380. https:\/\/doi.org\/10.1002\/cmdc.201100439.","journal-title":"ChemMedChem"},{"key":"3619_CR171","doi-asserted-by":"publisher","first-page":"2491","DOI":"10.1007\/s00204-019-02538-y","volume":"93","author":"M Simunkova","year":"2019","unstructured":"Simunkova M, Alwasel SH, Alhazza IM, Jomova K, Kollar V, Rusko M, et al. Management of oxidative stress and other pathologies in Alzheimer\u2019s disease. Arch Toxicol. 2019;93:2491\u2013513. https:\/\/doi.org\/10.1007\/s00204-019-02538-y.","journal-title":"Arch Toxicol"},{"key":"3619_CR172","doi-asserted-by":"publisher","first-page":"33","DOI":"10.3233\/JAD-200443","volume":"77","author":"C Calfio","year":"2020","unstructured":"Calfio C, Gonzalez A, Singh SK, Rojo LE, Maccioni RB. The emerging role of nutraceuticals and phytochemicals in the prevention and treatment of Alzheimer\u2019s disease. J Alzheimers Dis JAD. 2020;77:33\u201351. https:\/\/doi.org\/10.3233\/JAD-200443.","journal-title":"J Alzheimers Dis JAD"},{"key":"3619_CR173","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2022.884345","volume":"16","author":"BA Bhat","year":"2022","unstructured":"Bhat BA, Almilaibary A, Mir RA, Aljarallah BM, Mir WR, Ahmad F, et al. Natural therapeutics in aid of treating Alzheimer\u2019s disease: a green gateway toward ending quest for treating neurological disorders. Front Neurosci. 2022;16:884345. https:\/\/doi.org\/10.3389\/fnins.2022.884345.","journal-title":"Front Neurosci"},{"key":"3619_CR174","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.jalz.2013.05.1771","volume":"10","author":"S Lopes da Silva","year":"2014","unstructured":"Lopes da Silva S, Vellas B, Elemans S, Luchsinger J, Kamphuis P, Yaffe K, et al. Plasma nutrient status of patients with Alzheimer\u2019s disease: systematic review and meta-analysis. Alzheimers Dement J Alzheimers Assoc. 2014;10:485\u2013502. https:\/\/doi.org\/10.1016\/j.jalz.2013.05.1771.","journal-title":"Alzheimers Dement J Alzheimers Assoc"},{"key":"3619_CR175","doi-asserted-by":"publisher","first-page":"799824","DOI":"10.3389\/fnagi.2021.799824","volume":"13","author":"K Du","year":"2021","unstructured":"Du K, Zheng X, Ma ZT, Lv JY, Jiang WJ, Liu MY. Association of circulating magnesium levels in patients with Alzheimer\u2019s disease from 1991\u20132021: a systematic review and meta-analysis. Front Aging Neurosci. 2021;13:799824 https:\/\/doi.org\/10.3389\/fnagi.2021.799824.","journal-title":"Front Aging Neurosci"},{"key":"3619_CR176","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.neuint.2019.03.014","volume":"126","author":"DH Toffa","year":"2019","unstructured":"Toffa DH, Magnerou MA, Kassab A, Hassane Djibo F, Sow AD. Can magnesium reduce central neurodegeneration in Alzheimer\u2019s disease? Basic evidences and research needs. Neurochem Int. 2019;126:195\u2013202. https:\/\/doi.org\/10.1016\/j.neuint.2019.03.014.","journal-title":"Neurochem Int"},{"key":"3619_CR177","doi-asserted-by":"publisher","first-page":"730","DOI":"10.3390\/nu10060730","volume":"10","author":"AE Kirkland","year":"2018","unstructured":"Kirkland AE, Sarlo GL, Holton KF. The role of magnesium in neurological disorders. Nutrients. 2018;10:730 https:\/\/doi.org\/10.3390\/nu10060730.","journal-title":"Nutrients"},{"key":"3619_CR178","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.arr.2016.10.003","volume":"35","author":"P Wang","year":"2017","unstructured":"Wang P, Wang ZY. Metal ions influx is a double edged sword for the pathogenesis of Alzheimer\u2019s disease. Ageing Res Rev. 2017;35:265\u201390. https:\/\/doi.org\/10.1016\/j.arr.2016.10.003.","journal-title":"Ageing Res Rev"}],"container-title":["Translational Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41398-025-03619-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-025-03619-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-025-03619-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T15:44:50Z","timestamp":1760715890000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41398-025-03619-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,17]]},"references-count":178,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3619"],"URL":"https:\/\/doi.org\/10.1038\/s41398-025-03619-6","relation":{},"ISSN":["2158-3188"],"issn-type":[{"value":"2158-3188","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,17]]},"assertion":[{"value":"27 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study has obtained written informed consent from all participants or their agents.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent statement"}}],"article-number":"410"}}